Catalyst Wire Dossier Catalyst Wire Dossier

TERLIVAZ

terlipressin · Mallinckrodt Hospital Products Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TERLIVAZ, covering 2022-09-14 to 2023-01-09. Get the full timeline:

Most recent: FDA Approved: TERLIVAZ — Supplemental Application (Mallinckrodt Hospital Products Inc.)

See pricing